Correlation between in vitro chemotherapy sensitivity and PARP-1 expression in patients with breast cancer.

被引:0
|
作者
Liedtke, Cornelia
Packeisen, Jens
Denkert, Carsten
Kiesel, Ludwig
Vogt, Ulf
Mueller, Berit
Hess, Kenneth R.
Buerger, Horst
机构
[1] Univ Munster, D-48149 Munster, Germany
[2] Inst Pathol, Osnabruck, Germany
[3] Charite, Inst Pathol, D-13353 Berlin, Germany
[4] Univ Hosp Munster, Munster, Germany
[5] European Lab Assoc, Ibbenburen, Germany
[6] Charite, D-13353 Berlin, Germany
[7] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[8] Inst Pathol, Paderborn, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
10627
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Correlation Between PARP-1 Expression and In-vitro Chemotherapy Sensitivity in Patients With Breast Cancer
    Liedtke, C.
    Packeisen, J.
    Denkert, C.
    Gluz, O.
    Tio, J.
    Kiesel, L.
    Vogt, U.
    Mueller, B.
    Hess, K. R.
    Buerger, H.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S383 - S383
  • [2] PET imaging of PARP-1 expression in breast cancer
    McDonald, E. S.
    Carlin, S.
    Maxwell, K. N.
    Nayak, A.
    Doot, R. K.
    Pantel, A. R.
    Farwell, M. D.
    Pryma, D. A.
    Clark, A. S.
    Shah, P.
    DeMichele, A. M.
    Ziober, A.
    Schubert, E. K.
    Palmer, K.
    Lee, H. S.
    Matro, J.
    de la Cruz, L.
    Tchou, J.
    Anderson, D. N.
    Feldman, M. D.
    Sheffer, R. E.
    Knollman, H.
    Schnall, M. D.
    Makvandi, M.
    Domchek, S.
    Hubbard, R. A.
    Mach, R. H.
    Mankoff, D. A.
    CANCER RESEARCH, 2019, 79 (04)
  • [3] PARP-1 Expression and BRCA1 Mutations in Breast Cancer Patients' CTCs
    Sklias, Thodoris
    Vardas, Vasileios
    Pantazaka, Evangelia
    Christopoulou, Athina
    Georgoulias, Vassilis
    Kotsakis, Athanasios
    Vasilopoulos, Yiannis
    Kallergi, Galatea
    CANCERS, 2022, 14 (07)
  • [4] Correlation between PARP-1 immunoreactivity and cytomorphological features of parthanatos, a specific cellular death in breast cancer cells
    Donizy, P.
    Halon, A.
    Surowiak, P.
    Pietrzyk, G.
    Kozyra, C.
    Matkowski, R.
    EUROPEAN JOURNAL OF HISTOCHEMISTRY, 2013, 57 (04): : 236 - 239
  • [5] The Prognostic and Predictive Significance of PARP-1 in Locally Advanced Breast Cancer of Egyptian Patients Receiving Neoadjuvant Chemotherapy
    Aiad, Hayam A.
    Kandil, Mona A. H.
    El-Tahmody, Mohammed A.
    Abulkheir, Iman L.
    Abulkasem, Fatma M.
    Elmansori, Asma A.
    Aleskandarany, Mohammed A.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2015, 23 (08) : 571 - 579
  • [6] 18F-radiolabeled PARP-1 inhibitor uptake as a marker of PARP-1 activity in breast cancer
    Edmonds, C. E.
    Lieberman, B. P.
    Xu, K.
    Zeng, C.
    Makvandi, M.
    Li, S.
    Hou, C.
    Lee, H.
    Greenberg, R. A.
    Mankoff, D. A.
    Mach, R. H.
    CANCER RESEARCH, 2016, 76
  • [7] CLINICAL CORRELATION BETWEEN IN VITRO DRUG SENSITIVITY AND RESPONSE TO ADJUVANT CHEMOTHERAPY IN BREAST-CANCER
    SCHLAG, P
    SCHREML, W
    BREITIG, D
    BETZLER, M
    HERFARTH, C
    LANGENBECKS ARCHIV FUR CHIRURGIE, 1981, : 241 - 246
  • [8] Correlation between miRNA and gene expression profiles and response to neoadjuvant chemotherapy in patients with locally advanced and inflammatory breast cancer.
    Somlo, G.
    Li, S. M.
    Wu, X.
    Lau, S.
    Frankel, P. H.
    Kruper, L.
    Gao, H.
    Sun, G.
    Yim, J. H.
    Hurria, A.
    Mortimer, J. E.
    De Snoo, F.
    Paz, I. B.
    Rossi, J.
    Wang, E.
    Roepman, P.
    Yen, Y.
    van't Veer, L.
    Bender, R. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [9] Exploring the significance of PARP-1 expression for therapy and clinical PET/CT imaging of PARP-1 in ovarian cancer
    Makvandi, Mehran
    Pantel, Austin
    Schwartz, Lauren E.
    Xu, Kuiying
    Hsieh, Chia-Ju
    Kim, Hyoung
    Li, Shi-Hong
    Doot, Robert
    Lee, Sharon
    Simpkins, Fiona
    Greenberg, Roger A.
    Mankoff, David A.
    Mach, Robert H.
    Lin, Lilie
    CANCER RESEARCH, 2017, 77
  • [10] Correlation between Aromatase Expression in Metastatic and Primary Breast Cancer.
    Ribeiro, J. M.
    Luis, I. V.
    Correia, L.
    Casimiro, S.
    Fernandes, A.
    Quintela, A.
    Mestan, J.
    Ramos, M.
    Costa, L.
    CANCER RESEARCH, 2011, 71